0001061983-20-000189.txt : 20201217
0001061983-20-000189.hdr.sgml : 20201217
20201217180519
ACCESSION NUMBER: 0001061983-20-000189
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201215
FILED AS OF DATE: 20201217
DATE AS OF CHANGE: 20201217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cragg David
CENTRAL INDEX KEY: 0001316459
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50633
FILM NUMBER: 201397319
MAIL ADDRESS:
STREET 1: 280 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYTOKINETICS INC
CENTRAL INDEX KEY: 0001061983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943291317
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 280 EAST GRAND AVENUE
STREET 2: .
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 624-3000
MAIL ADDRESS:
STREET 1: 280 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-12-15
0
0001061983
CYTOKINETICS INC
CYTK
0001316459
Cragg David
280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
SVP Human Resources
Common Stock
2020-12-15
4
M
0
7423
9.42
A
147639
D
Common Stock
2020-12-15
4
F
0
4745
21.0
D
142894
D
Common Stock
2020-12-15
4
M
0
9243
9.42
A
152137
D
Common Stock
2020-12-15
4
F
0
5908
21.0
D
146229
D
Incentive Stock Option (right to buy)
9.42
2020-12-15
4
C
0
7423
0.0
D
2011-03-31
2021-02-28
Common Stock
7423
1
D
Non-Qualified Stock Option (right to buy)
9.42
2020-12-15
4
C
0
7423
0.0
A
2011-03-31
2021-02-28
Common Stock
7423
16666
D
Non-Qualified Stock Option (right to buy)
9.42
2020-12-15
4
M
0
7423
0.0
D
2011-03-31
2021-02-28
Common Stock
7423
9243
D
Non-Qualified Stock Option (right to buy)
9.42
2020-12-15
4
M
0
9243
0.0
D
2011-03-31
2021-02-28
Common Stock
9243
0
D
Includes up to 13,132 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan.
Transaction represents a "net exercise" of 9,243 outstanding non-qualified stock options granted on 2/28/2011 and 7,423 outstanding non-qualified stock options that result from the conversion on 12/15/20 of incentive stock options granted on 2/28/2011. The Reporting Person received 6,013 shares of Common Stock on the net exercise of a stock options to purchase an aggregate of 16,666 shares of Common Stock, with a remaining payable by Reporting Person to the Issuer of $17.45. The Issuer withheld 10,653 shares of Common Stock underlying the stock options for payment of the exercise price and tax withholding using a stock price on 12/15/20 of $21.00. In addition to the withholding of 10,653 shares of Common Stock, the Reporting Person will pay $17.45 in cash to the Issuer for the remainder of his exercise price and tax liability.
Incentive stock options granted on 2/28/2011 to purchase 7,423 shares at an exercise price of $9.42 per share converted to non-qualified stock options to purchase 7,423 shares at an exercise price of $9.42 per share as a result of a modification to the original grant to permit a "net exercise" of the stock options. Conversion transaction is permitted pursuant to the Issuer's Amended and Restated 2004 Equity Incentive Plan and the prior resolution of the Issuer's Compensation and Talent Committee of the Board of Directors.
Number of derivative securities beneficially owned following reported transaction is zero (0). The 1 security that is reported is the result of rounding of shares attributable to Issuer?s reverse stock split that occurred on 6/25/2013.
By: Robert Wong For: David Cragg
2020-12-17